Trinity Biotech PLC
NASDAQ:TRIB
Trinity Biotech PLC
Interest Income Expense
Trinity Biotech PLC
Interest Income Expense Peer Comparison
Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors
Company | Interest Income Expense | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Trinity Biotech PLC
NASDAQ:TRIB
|
Interest Income Expense
-$9.9m
|
CAGR 3-Years
-14%
|
CAGR 5-Years
-18%
|
CAGR 10-Years
N/A
|
|
Medtronic PLC
NYSE:MDT
|
Interest Income Expense
-$219m
|
CAGR 3-Years
20%
|
CAGR 5-Years
21%
|
CAGR 10-Years
-2%
|
|
STERIS plc
NYSE:STE
|
Interest Income Expense
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Trinity Biotech PLC's Interest Income Expense?
Interest Income Expense
-9.9m
USD
Based on the financial report for Dec 31, 2023, Trinity Biotech PLC's Interest Income Expense amounts to -9.9m USD.
What is Trinity Biotech PLC's Interest Income Expense growth rate?
Interest Income Expense CAGR 5Y
-18%
Over the last year, the Interest Income Expense growth was 60%. The average annual Interest Income Expense growth rates for Trinity Biotech PLC have been -14% over the past three years , -18% over the past five years .